Lyxor STOXX Europe 600 Healthcare UCITS ETF
Why invest in this sector?
Lyxor STOXX Europe 600 Healthcare UCITS ETF - Acc is a UCITS compliant exchange-traded fund that aims to track the benchmark STOXX Europe 600 Health Care Net Return EUR. The STOXX Europe 600 Health Care Net Return EUR comprises the largest healthcare industry stocks in Europe. The STOXX Europe 600 Supersectors are derived from the STOXX Europe 600, which includes the 600 largest European stocks by free market capitalization. They represent the largest European companies in each of the 18 supersectors defined by the ICB classification (Industry Classification Benchmark).
Sectoral mood
Geographical location
Target markets
Documents to download
Client category
Non-Professional Investor, Professional Investor, Eligible Counterparty
Knowledge and experience
Basic Investor, Informed Investor, Experienced Investor
Investment horizon
<5 years
Investment objective
Grow
Ability to bear losses
Yes
Risk tolerance
6
Communication of key information for the investor
Characteristics
The communication is not a proposal by Imperium Finance s.r.o. to conclude a contract. Investment instruments are associated with the risk of fluctuations in the current value of the invested amount and its return is not guaranteed. Revenues are reported in gross values. The communication contains information about past performance, which is not a reliable indicator of future results. In order to obtain net income values, the investor must take into account the fees charged by Imperium Finance according to the valid price list and any taxation, which depends on the personal circumstances of the investor and may change. Imperium Finance advises investors with a different domestic currency that returns may rise or fall due to fluctuations in exchange rates. The communication is only informative, it does not replace the fund status or key information communication (KIID). Imperium Finance points out that the target market was not taken into account in the message - you may be outside the target market, or even in the negative target market of the listed investment instruments.